인에잇바이오 (INAB)

In 8 Bio Inc (INAB) 재무 분석

손익 계산서

분기별

*모든 숫자는 백만 단위입니다.

기간 종료일	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
기간	3개월	3개월	3개월	3개월	3개월
Revenues	125.15% 0.083	-0.33	-	-	0.33
Operating Expenses	13.78% 8.645	7.598	7.169	7.715	7.855
Benefits Costs and Expenses	8.645	-	7.169	7.715	7.855
Costs And Expenses	8.645	-	7.169	7.715	7.855
Operating Income/Loss	8.00% -8.562	-7.928	-7.169	-7.715	-7.525
Income/Loss From Continuing Operations Before Tax	35.81% -8.562	-13.34	-7.169	-7.715	-7.525
Income/Loss From Continuing Operations After Tax	12.69% -8.562	-7.598	-7.169	-7.715	-7.525
Net Income/Loss	12.69% -8.562	-7.598	-7.169	-7.715	-7.525
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,623% 43.29	1.5897	31.55	28.47	24.73
Diluted Average Shares	2,623% 43.29	1.5897	31.55	28.47	24.73
Basic Earnings Per Share	4.76% -0.20	-0.21	-0.23	-0.27	-0.30
Diluted Earnings Per Share	4.76% -0.20	-0.21	-0.23	-0.27	-0.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-